Biogen Statement Regarding Updated ADUHELM® (aducanumab-avwa) Prescribing Information in US

Friday, April 29, 2022 1 min read

Key Takeaway: Biogen Statement Regarding Updated ADUHELM® (aducanumab-avwa) Prescribing Information in US

Full Press Release Details

Biogen Statement Regarding Updated ADUHELM® (aducanumab-avwa) Prescribing Information in US.